Infliximab can induce a prolonged clinical remission and a decrease in thyroid hormonal requirements in a patient with SAPHO syndrome and hypothyroidism

Author： Sabugo Francisca   Liberman Claudio   Niedmann Juan   Soto Lilian   Cuchacovich Miguel  

Publisher： Springer Publishing Company

ISSN： 0770-3198

Source： Clinical Rheumatology, Vol.27, Iss.4, 2008-04, pp. : 533-535

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The SAPHO syndrome: a clinical and imaging study

By Sallés Meritxell   Olivé Alejandro   Perez-Andres Ricard   Holgado Susana   Mateo Lourdes   Riera Elena   Tena Xavier  

Clinical Rheumatology, Vol. 30, Iss. 2, 2011-02 ,pp. : 245-249

Springer Publishing Company

Access to resources Recommend Favorite

Clinical and Radiological Characteristics of SAPHO Syndrome

By  

Current Rheumatology Reviews, Vol. 9, Iss. 1, 2013-02 ,pp. : 22-27

Bentham Science Publishers

Access to resources Recommend Favorite

Bone scintigraphy using Tc-99m DPD and F18-FDG in a patient with SAPHO syndrome

By Pichler Robert   Pichler Robert   Pichler Robert   Pichler Robert   Pichler Robert  

Scandinavian Journal of Rheumatology, Vol. 32, Iss. 1, 2003-01 ,pp. : 58-60

Informa Healthcare

Access to resources Recommend Favorite

Pourfour du Petit Syndrome in a Patient with Thyroid Carcinoma

By  

Case Reports in Neurology, Vol. 2, Iss. 2, 2010-07 ,pp. : 96-100

Karger

Access to resources Recommend Favorite

Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study

By Steenholdt Casper   Molazahi Akbar   Ainsworth Mark Andrew   Brynskov Jørn   Thomsen Ole Østergaard   Seidelin Jakob Benedict  

Scandinavian Journal of Gastroenterology, Vol. 47, Iss. 5, 2012-05 ,pp. : 518-527

Informa Healthcare

Access to resources Recommend Favorite